- Home
- OABI vs ACNB Comparison
OABI vs ACNB Comparison
Compare OABI & ACNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- ACNB
- Stock Information
- Founded
- OABI 2012
- ACNB 1857
- Country
- OABI United States
- ACNB United States
- Employees
- OABI N/A
- ACNB N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- ACNB Major Banks
- Sector
- OABI Health Care
- ACNB Finance
- Exchange
- OABI Nasdaq
- ACNB Nasdaq
- Market Cap
- OABI 388.5M
- ACNB 331.1M
- IPO Year
- OABI N/A
- ACNB N/A
- Fundamental
- Price
- OABI $3.22
- ACNB $39.92
- Analyst Decision
- OABI Strong Buy
- ACNB Buy
- Analyst Count
- OABI 4
- ACNB 3
- Target Price
- OABI $9.00
- ACNB $45.00
- AVG Volume (30 Days)
- OABI 448.8K
- ACNB 23.7K
- Earning Date
- OABI 11-12-2024
- ACNB 01-31-2025
- Dividend Yield
- OABI N/A
- ACNB 3.21%
- EPS Growth
- OABI N/A
- ACNB N/A
- EPS
- OABI N/A
- ACNB 3.44
- Revenue
- OABI $20,409,000.00
- ACNB $106,401,000.00
- Revenue This Year
- OABI N/A
- ACNB N/A
- Revenue Next Year
- OABI $78.61
- ACNB $20.49
- P/E Ratio
- OABI N/A
- ACNB $11.51
- Revenue Growth
- OABI N/A
- ACNB N/A
- 52 Week Low
- OABI $3.16
- ACNB $30.24
- 52 Week High
- OABI $6.55
- ACNB $50.72
- Technical
- Relative Strength Index (RSI)
- OABI 32.70
- ACNB 44.26
- Support Level
- OABI $3.16
- ACNB $35.89
- Resistance Level
- OABI $3.29
- ACNB $39.67
- Average True Range (ATR)
- OABI 0.13
- ACNB 1.11
- MACD
- OABI -0.02
- ACNB 0.28
- Stochastic Oscillator
- OABI 9.09
- ACNB 77.68
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. The company focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About ACNB ACNB Corporation
ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Bank which generates the majority of the revenue provides banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.